PDF herunterladen
Horm Metab Res 2005; 37(3): 184-188
DOI: 10.1055/s-2005-861304
Original Clinical
© Georg Thieme Verlag KG Stuttgart · New York

Sex Hormones in Patients with Epilepsy - Hormonal Changes in Epileptic Men and Women Taking Antiepileptics

M.  Ciampani1 , A.  Verrotti1 , F.  Chiarelli1
  • 1Department of Pediatrics, University of Chieti, Italy
Weitere Informationen

Publikationsverlauf

Received 3 May 2004

Accepted after revision 1 September 2004

Publikationsdatum:
12. April 2005 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

The relationship between epilepsy and endocrine system has attracted the attention of investigators for a number of years. Epilepsy is a common neurological disorder; both seizures and antiepileptic drugs can compromise the physical and hormonal aspects of sexual development. Impairment of libido and sexual potency have been frequently reported in male epileptic patients. Women with epilepsy have a greater risk of infertility (anovulatory cycles and polycystic ovary syndrome). This review analyses the main data from the literature in order to clarify the role of epilepsy and antiepileptic drugs on sex hormones in epileptic patients. As gonad dysfunction is frequently observed in women and men with epilepsy, particularly when taking antiepileptic drugs, ovarian and testicular function must be carefully monitored.

Key words

Antiepileptic drugs - Impaired fertility - Sexual development - Valproic acid - Carbamazepine - Lamotrigine

References

  • 1 Snyder P J, Badura L L. A potential mechanism of slowed pubertal maturation after chronic administration of sodium valproic acid.  Neurology. 1998;  50 922-925
    PubMedGoogle Scholar
  • 2 Isojärvi J IT, Laatikainen T J, Knip M, Pakarinen A J, Juntunen K TS, Myllylä V V. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.  N Engl J Med. 1993;  329 1383-1388
    CrossrefPubMedGoogle Scholar
  • 3 Saunders M, Rawson M. Sexuality in male epileptics.  J Neurol Sci. 1970;  10 577-583
    CrossrefPubMedGoogle Scholar
  • 4 Taylor D C. Sexual behavior in temporal lobe epilepsy.  Arc Neurol. 1969;  21 510-516
    PubMedGoogle Scholar
  • 5 Morell M J, Sauer M, Guidice L. Pituitary gonadotropin function in women with epilepsy.  Epilepsia. 2000;  41 (Suppl 7) 247
    PubMedGoogle Scholar
  • 6 Drislane F W, Coleman A E, Schomer D L. Altered pulsatile secretion of luteinizing hormone in women with epilepsy.  Neurology. 1994;  44 306-310
    PubMedGoogle Scholar
  • 7 Morell M J. Reproductive and metabolic disorders in women with epilepsy.  Epilepsia. 2003;  44 (Suppl 4) 11-20
    PubMedGoogle Scholar
  • 8 Herzog A G, Coleman A E, Jacobs A R. Menstrual disorders reproductive endocrine dysfunction and interictal discharge frequency in women with temporolimbic epilepsy.  Neurology. 1999;  52 (Suppl 2) A24
    PubMedGoogle Scholar
  • 9 Morell M J, Giudice L, Flynn K L, Seale C G, Paulson A J, Done S, Flaster E, Ferin M, Sauer M V. Predictors of ovulatory failure in women with epilepsy.  Ann Neurol. 2002;  52 704-711
    CrossrefPubMedGoogle Scholar
  • 10 Herzog A G, Seibel M M, Schomer D L. Temporal lobe epilepsy: an extrahypotalamic pathogenesis for polycystic ovarian syndrome?.  Neurology. 1984;  34 1389-1393
    PubMedGoogle Scholar
  • 11 Isojärvi J IT, Laatikainen T J, Knip M, Pakarinen A J, Juntunen K TS, Myllylä V V. Polycystic ovaries and hyperandrogenism in women taking valproate.  New Engl J Med. 1993;  329 1383-1388
    CrossrefPubMedGoogle Scholar
  • 12 Bauer J, Jarred A, Klingmuller D, Elgar C E. Polycystic ovary syndrome in patients with focal epilepsy. A study in 93 women.  Epilepsy Res. 2000;  41 163-167
    CrossrefPubMedGoogle Scholar
  • 13 Duncan S. Polycystic ovarian syndrome in women with epilepsy: a review.  Epilepsia. 2001;  42 60-65
    CrossrefPubMedGoogle Scholar
  • 14 Stanhope R, Adams J, Jacobs H S, Brook C GD. Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment in hypogondotropic hypogonadism.  Arch Dis Child. 1985;  60 116-119
    PubMedGoogle Scholar
  • 15 Polson D W. Polycystic ovary syndrome and epilepsy a gynaecological perspective.  Seizure. 2003;  12 397-402
    CrossrefPubMedGoogle Scholar
  • 16 Adams J, Franks S, Polson D W. Multi-follicular ovaries: clinical and endocrine features and response to pulsatile gonadotrophin-releasing hormone.  Lancet. 1985;  2 1375-1379
    PubMedGoogle Scholar
  • 17 Zawadski J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Meriiam GR Polycystic ovary syndrome. Oxford; Blackwell Scientific 1992: 377-384
    Google Scholar
  • 18 Knochenhauser E S, Key T J, Kashar-Miller M. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.  J Clin Endocrinol Metab. 1998;  83 3078-3082
    CrossrefPubMedGoogle Scholar
  • 19 Herzog A G, Seibel M M, Schomer D L, Vaitukaitis J L, Geschwind N. Reproductive endocrine disorder in women with partial seizures of temporal lobe origin.  Arch Neurol. 1986;  43 341-346
    CrossrefPubMedGoogle Scholar
  • 20 Herzog A G, Levesque L, Drislane F, Ronthal M, Schomer D. Phenytoin induced elevations of serum estradiol and reproductive dysfunction in men with epilepsy.  Epilepsia. 1991;  32 550-553
    PubMedGoogle Scholar
  • 21 Herzog A G. A hypothesis to integrate partial seizure of temporal lobe origin and reproductive endocrine disorders.  Epilepsy Res. 1989;  3 151-159
    CrossrefPubMedGoogle Scholar
  • 22 Murialdo G, Galimberti C A, Fonzi S, Manni R, Costelli P, Parodi C, Solinas G P, Amoretti G, Tartara A. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality.  Epilepsia. 1995;  36 360-366
    CrossrefPubMedGoogle Scholar
  • 23 Herzog A G. Reproductive endocrine considerations and hormonal therapy in men with epilepsy.  Epilepsy. 1991;  32 (Suppl 6) S34-S37
    PubMedGoogle Scholar
  • 24 Murialdo G, Galimberti C A, Fonzi S, Manni R, Costelli P, Parodi C, Solinas G P, Amoretti G, Tartara A. Sex hormones, gonadotropin and prolactin in male epileptic subject in remission: role of the epileptic syndrome and of antiepileptic drugs.  Neuropsycobiol. 1994;  30 29-36
    PubMedGoogle Scholar
  • 25 Ramsay R E, Salter J D. Effects of antiepileptic drugs on hormones.  Epilepsia. 1991;  32 (Suppl 6) S60-S67
    PubMedGoogle Scholar
  • 26 El-Khayat H A, Shatla H M, Ali G KH, Abdulgani M O, Tomoum H Y, Attya H A. Physical and hormonal profile of male sexual development in epilepsy.  Epilepsia. 2003;  44 447-452
    CrossrefPubMedGoogle Scholar
  • 27 Isojärvi J IT, Pakarinen A J, Schmaltz S. Testosterone levels in adult male epileptic patients.  Neurology. 1987;  37 706-708
    PubMedGoogle Scholar
  • 28 Franceschi M, Perego L, Cavagnini F. Effects of long-term antiepileptic therapy on hypothalamic-pituitary axis in men.  Epilepsia. 1984;  25 46-52
    PubMedGoogle Scholar
  • 29 Kurowski H L, Gospe S M, Zeman F J. Nutritional factors and anticonvulsant therapies: effect on growth in children with epilepsy.  Am J Clin Nutr. 1993;  58 858-861
    PubMedGoogle Scholar
  • 30 Macardle B M, McGowan M EL, Greene S A. Anticonvulsant drugs, growth and development.  Arch Dis Child. 1987;  62 615-617
    PubMedGoogle Scholar
  • 31 Verrotti A, Basciani F, Morresi S, Cutarella R, Morgese G, Chiarelli F. Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal.  Eur J Ped. 2000;  159 871-872
    PubMedGoogle Scholar
  • 32 Vainionpää L K, Rättyä J, Knip M, Tapanainen J S, Pakarinen A J, Lanning P, Tekay A, Myllylä V V, Isojärvi J IT. Valproate induced hyperandrogenism during pubertal maturation in girls with epilepsy.  Ann Neurol. 1999;  45 444-450
    CrossrefPubMedGoogle Scholar
  • 33 Verrotti A, Basciani F, de Simone M, Trotta D, Morgese G, Chiarelli F. Insulin resistance in epileptic girl who weight gain after therapy with valproic acid.  J Child Neurol. 2002;  17 265-268
    PubMedGoogle Scholar
  • 34 Isojärvi J IT, Laatikainen T J, Knip M. Obesity and endocrine disorders in women taking valproate for epilepsy.  Ann Neurol. 1996;  39 579-584
    CrossrefPubMedGoogle Scholar
  • 35 Verrotti A, Basciani F, Morresi S, de Martino M, Morgese G, Chiarelli F. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid.  Neurology. 1999;  13 : 53 230-232
    PubMedGoogle Scholar
  • 36 Adkeniz F, Tanelli F, Noyan A, Yuncu Z, Vahip S. Valproate associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?.  Prog Neur Biol Psychiatry. 2003;  27 115-121
    PubMedGoogle Scholar
  • 37 Morell M J, Isojärvi J, Taylor A E, Dam M, Ayala R, Gomez G, O’Neill F, Tennis P, Messenheimer J. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.  Epilepsy Res. 2003;  54 189-199
    CrossrefPubMedGoogle Scholar
  • 38 Isojärvi J IT, Laatikainen T J, Parakinen A J, Juntunen K TS, Myllylä V V. Menstrual disorders in women with epilepsy receiving carbamazepine.  Epilepsia. 1995;  36 676-681
    PubMedGoogle Scholar
  • 39 Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary sindrome in premenopausal women.  Clin Endocrinol. 1993;  39 1-16
    CrossrefPubMedGoogle Scholar
  • 40 Isojärvi J I, Rättyä J, Myllylä V V. Valproate, lamotrigine, and insulin mediated risk in women with epilepsy.  Ann Neurol. 1998;  43 446-451
    CrossrefPubMedGoogle Scholar
  • 41 Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.  Seizure. 2003;  12 323-329
    CrossrefPubMedGoogle Scholar

Francesco Chiarelli, M. D.

Department of Pediatrics, University of Chieti

Via dei Vestini 5 · 66100 Chieti · Italy

Telefon: +39 0871 358015

Fax: +39 0871 574831

eMail: chiarelli@unich.it

eMail: averott@unich.it; mpciampani@katamail.com